| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.04 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.05 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.092 | 0.05 |